Similarly, both coding (rare sequence variants and a common in frame insertion) and non-coding sequence variants in the complement receptor 1 (CR1) have been associated with late-onset AD (Hazrati et al., 2012; Jun et al., 2010; Naj et al., 2011; Wyss-Coray et al., 2002). This evidence concerns the gene CR1 and Alzheimer disease.